ion Therapeutics, Inc. (“Sevion” or the “Company”) (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today reported financial results for the fiscal quarter ended December 31, 2014 (“Second Quarter 2015”).
Help employers find you! Check out all the jobs and post your resume.
